Yamaguchi, Ayane
Honda, Maya
Ishiguro, Hiroshi
Kataoka, Masako
Kataoka, Tatsuki R.
Shimizu, Hanako
Torii, Masae
Mori, Yukiko
Kawaguchi-Sakita, Nobuko
Ueno, Kentaro
Kawashima, Masahiro
Takada, Masahiro
Suzuki, Eiji
Nakamoto, Yuji
Kawaguchi, Kosuke
Toi, Masakazu
Article History
Received: 11 January 2021
Accepted: 26 April 2021
First Online: 12 May 2021
Competing interests
: Takada M has received research grant from Eisai, Daiichi Sankyo, AstraZeneca, KBCRN, and ABCSG, and has received honorarium from Chugai Pharmaceutical Co, Eli Lilly, Eisai, Daiichi Sankyo, AstraZeneca, Pfizer, Kyowa Hakko Kirin, and Nippon Kayaku. Prof. Toi reports grants from Chugai Pharmaceutical Co, Eisai, BMS, Kyowa Hakko Kirin, Nippon Kayaku, JBCRG association, AstraZeneca, Shimadzu Corporation, and Athenex Oncology. The other authors report no conflicts of interest.